|
Gene: ACP6 |
Gene summary for ACP6 |
Gene summary. |
Gene information | Species | Human | Gene symbol | ACP6 | Gene ID | 51205 |
Gene name | acid phosphatase 6, lysophosphatidic | |
Gene Alias | ACPL1 | |
Cytomap | 1q21.2 | |
Gene Type | protein-coding | GO ID | GO:0002244 | UniProtAcc | Q9NPH0 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51205 | ACP6 | LZE24T | Human | Esophagus | ESCC | 4.77e-23 | 5.10e-01 | 0.0596 |
51205 | ACP6 | P2T-E | Human | Esophagus | ESCC | 1.38e-06 | 1.35e-01 | 0.1177 |
51205 | ACP6 | P4T-E | Human | Esophagus | ESCC | 2.46e-17 | 3.34e-01 | 0.1323 |
51205 | ACP6 | P8T-E | Human | Esophagus | ESCC | 1.65e-03 | 4.46e-02 | 0.0889 |
51205 | ACP6 | P9T-E | Human | Esophagus | ESCC | 1.34e-02 | 4.36e-02 | 0.1131 |
51205 | ACP6 | P10T-E | Human | Esophagus | ESCC | 1.44e-09 | 1.15e-01 | 0.116 |
51205 | ACP6 | P12T-E | Human | Esophagus | ESCC | 6.81e-13 | 1.05e-01 | 0.1122 |
51205 | ACP6 | P15T-E | Human | Esophagus | ESCC | 1.75e-08 | 1.17e-01 | 0.1149 |
51205 | ACP6 | P16T-E | Human | Esophagus | ESCC | 2.62e-06 | 1.10e-01 | 0.1153 |
51205 | ACP6 | P17T-E | Human | Esophagus | ESCC | 1.77e-05 | 1.93e-01 | 0.1278 |
51205 | ACP6 | P20T-E | Human | Esophagus | ESCC | 8.14e-05 | 1.17e-01 | 0.1124 |
51205 | ACP6 | P22T-E | Human | Esophagus | ESCC | 1.31e-09 | 1.81e-01 | 0.1236 |
51205 | ACP6 | P23T-E | Human | Esophagus | ESCC | 2.20e-11 | 1.71e-01 | 0.108 |
51205 | ACP6 | P24T-E | Human | Esophagus | ESCC | 1.56e-04 | 5.26e-02 | 0.1287 |
51205 | ACP6 | P26T-E | Human | Esophagus | ESCC | 1.38e-11 | 1.77e-01 | 0.1276 |
51205 | ACP6 | P27T-E | Human | Esophagus | ESCC | 1.34e-08 | 1.33e-01 | 0.1055 |
51205 | ACP6 | P28T-E | Human | Esophagus | ESCC | 2.34e-07 | 5.46e-02 | 0.1149 |
51205 | ACP6 | P37T-E | Human | Esophagus | ESCC | 5.55e-03 | 3.12e-02 | 0.1371 |
51205 | ACP6 | P39T-E | Human | Esophagus | ESCC | 3.98e-06 | 3.46e-02 | 0.0894 |
51205 | ACP6 | P42T-E | Human | Esophagus | ESCC | 1.54e-02 | 9.70e-02 | 0.1175 |
Page: 1 2 3 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001631110 | Esophagus | ESCC | dephosphorylation | 251/8552 | 417/18723 | 1.26e-09 | 2.99e-08 | 251 |
GO:00086544 | Esophagus | ESCC | phospholipid biosynthetic process | 162/8552 | 253/18723 | 2.59e-09 | 5.73e-08 | 162 |
GO:00464744 | Esophagus | ESCC | glycerophospholipid biosynthetic process | 135/8552 | 211/18723 | 5.75e-08 | 1.02e-06 | 135 |
GO:00450175 | Esophagus | ESCC | glycerolipid biosynthetic process | 154/8552 | 252/18723 | 5.20e-07 | 6.96e-06 | 154 |
GO:00066446 | Esophagus | ESCC | phospholipid metabolic process | 218/8552 | 383/18723 | 5.37e-06 | 5.59e-05 | 218 |
GO:00066505 | Esophagus | ESCC | glycerophospholipid metabolic process | 174/8552 | 306/18723 | 4.92e-05 | 3.85e-04 | 174 |
GO:00066541 | Esophagus | ESCC | phosphatidic acid biosynthetic process | 26/8552 | 33/18723 | 1.06e-04 | 7.43e-04 | 26 |
GO:00464733 | Esophagus | ESCC | phosphatidic acid metabolic process | 28/8552 | 37/18723 | 2.00e-04 | 1.26e-03 | 28 |
GO:00464864 | Esophagus | ESCC | glycerolipid metabolic process | 211/8552 | 392/18723 | 6.51e-04 | 3.46e-03 | 211 |
GO:00022446 | Esophagus | ESCC | hematopoietic progenitor cell differentiation | 66/8552 | 114/18723 | 5.74e-03 | 2.13e-02 | 66 |
GO:00086542 | Liver | HCC | phospholipid biosynthetic process | 150/7958 | 253/18723 | 4.77e-08 | 1.03e-06 | 150 |
GO:00066444 | Liver | HCC | phospholipid metabolic process | 214/7958 | 383/18723 | 7.25e-08 | 1.48e-06 | 214 |
GO:001631121 | Liver | HCC | dephosphorylation | 230/7958 | 417/18723 | 1.00e-07 | 1.96e-06 | 230 |
GO:004648611 | Liver | HCC | glycerolipid metabolic process | 215/7958 | 392/18723 | 4.54e-07 | 7.49e-06 | 215 |
GO:004501711 | Liver | HCC | glycerolipid biosynthetic process | 143/7958 | 252/18723 | 3.27e-06 | 4.31e-05 | 143 |
GO:00066504 | Liver | HCC | glycerophospholipid metabolic process | 168/7958 | 306/18723 | 7.27e-06 | 8.62e-05 | 168 |
GO:004647411 | Liver | HCC | glycerophospholipid biosynthetic process | 121/7958 | 211/18723 | 9.12e-06 | 1.06e-04 | 121 |
GO:0006654 | Liver | HCC | phosphatidic acid biosynthetic process | 23/7958 | 33/18723 | 1.46e-03 | 7.75e-03 | 23 |
GO:00464732 | Liver | HCC | phosphatidic acid metabolic process | 24/7958 | 37/18723 | 5.03e-03 | 2.11e-02 | 24 |
GO:0052646 | Liver | HCC | alditol phosphate metabolic process | 9/7958 | 11/18723 | 9.51e-03 | 3.60e-02 | 9 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ACP6 | SNV | Missense_Mutation | novel | c.717N>T | p.Met239Ile | p.M239I | protein_coding | deleterious(0.04) | benign(0.003) | TCGA-55-8621-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ACP6 | SNV | Missense_Mutation | novel | c.761N>G | p.Asp254Gly | p.D254G | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-37-4132-01 | Lung | lung squamous cell carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
ACP6 | SNV | Missense_Mutation | novel | c.1186N>C | p.Asp396His | p.D396H | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-CR-7364-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
ACP6 | SNV | Missense_Mutation | rs782479679 | c.520N>T | p.Arg174Cys | p.R174C | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D6-6516-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ACP6 | SNV | Missense_Mutation | c.1009N>G | p.Thr337Ala | p.T337A | protein_coding | deleterious(0.01) | possibly_damaging(0.482) | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | ||
ACP6 | insertion | In_Frame_Ins | novel | c.507_508insAGGTACACA | p.Asn169_Leu170insArgTyrThr | p.N169_L170insRYT | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |